Oaktree Acquisition Corp. III Life Sciences Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BOUSSARD & GAVAUDAN INVESTMENT MANAGEMENT LLP | 02/12/2026 | 720.00 K | $7.65 M | -4.00% | 3.75% |
| TORONTO DOMINION BANK | 02/17/2026 | 675.20 K | $7.14 M | -27.71% | 3.52% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 627.03 K | $6.63 M | -4.65% | 3.27% |
| SCULPTOR CAPITAL LP | 02/13/2026 | 530.54 K | $5.61 M | 6.11% | 2.76% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 529.54 K | $5.60 M | 0.00% | 2.76% |
| LMR PARTNERS LLP | 02/17/2026 | 510.90 K | $5.41 M | 0.00% | 2.66% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 400.00 K | $4.25 M | 0.00% | 2.08% |
| GRITSTONE ASSET MANAGEMENT LLC | 01/23/2026 | 394.91 K | $4.18 M | 0.00% | 2.06% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 377.07 K | $3.99 M | 67.09% | 1.96% |
| PERISCOPE CAPITAL INC. | 02/10/2026 | 323.40 K | $3.42 M | -19.15% | 1.68% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 309.74 K | $3.29 M | 91.50% | 1.61% |
| UBS OCONNOR LLC | 02/13/2026 | 300.00 K | $3.17 M | 0.00% | 1.56% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 02/10/2026 | 250.00 K | $2.65 M | -9.15% | 1.30% |
| BERKLEY W R CORP | 02/13/2026 | 223.65 K | $2.37 M | 0.00% | 1.16% |
| K2 PRINCIPAL FUND, L.P. | 02/13/2026 | 195.29 K | $2.07 M | 0.00% | 1.02% |
| METEORA CAPITAL, LLC | 02/17/2026 | 190.98 K | $2.02 B | -23.15% | 0.99% |
| UBS GROUP AG | 01/29/2026 | 100.48 K | $1.06 B | 1.78% | 0.52% |
| PICTON MAHONEY ASSET MANAGEMENT | 02/11/2026 | 75.00 K | $793.50 K | 0.00% | 0.39% |
| JPMORGAN CHASE & CO | 02/11/2026 | 49.89 K | $530.37 K | -33.31% | 0.26% |
| CITIGROUP INC | 02/13/2026 | 45.00 K | $478.35 K | -11.59% | 0.23% |
| CENTIVA CAPITAL, LP | 02/13/2026 | 40.40 K | $429.45 K | 0.00% | 0.21% |
| MIZUHO SECURITIES USA LLC | 02/09/2026 | 25.00 K | $260.00 K | -64.29% | 0.13% |
| CLEAR STREET GROUP INC. | 02/13/2026 | 21.00 K | $222.18 M | -4.55% | 0.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 15.24 K | $162.03 K | 0.00% | 0.08% |
| KEPOS CAPITAL LP | 02/12/2026 | 15.00 K | $159.00 K | 0.00% | 0.08% |
| BULLDOG INVESTORS, LLP | 02/13/2026 | 13.50 K | $142.83 K | 0.00% | 0.07% |
| MORGAN STANLEY | 02/13/2026 | 54 | $571 | 5,300.00% | 0.00% |
| DLD ASSET MANAGEMENT, LP | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
Oaktree Acquisition Corp. III Life Sciences institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Oaktree Acquisition Corp. III Life Sciences. The most heavily invested institutionals were:
Boussard & Gavaudan Investment Management LLP: 720,000
TORONTO DOMINION BANK: 675,197
HighTower Advisors, LLC: 627,029
Sculptor Capital LP: 530,537
GOLDMAN SACHS GROUP INC: 529,535
LMR Partners LLP: 510,900
23.68% of Oaktree Acquisition Corp. III Life Sciences stock is owned by institutional investors.
Institutional investors have bought a total of 6.56 M shares in the last 24 months. This purchase volume represents approximately $70.08 M in transactions.